Development of Conformationally Restricted Negamycin Derivatives for Potent Readthrough Activity-Reference-Cited by-同舟云学术

Development of Conformationally Restricted Negamycin Derivatives for Potent Readthrough Activity

Published:2023-12-04 Issue:12 Volume:14 Page:1807-1814
ISSN:1948-5875
Container-title:ACS Medicinal Chemistry Letters
language:en
Short-container-title:ACS Med. Chem. Lett.

Author:

Omura Noriko¹,Taguchi Akihiro¹,Kuwahara Tomoki²,Hamada Keisuke¹^ORCID,Watanabe Mizuki²^ORCID,Nakakuki Masanori³,Konno Sho¹,Takayama Kentaro¹^ORCID,Taniguchi Atsuhiko¹,Nomura Toshifumi⁴⁵,Shuto Satoshi²^ORCID,Hayashi Yoshio¹^ORCID

Affiliation:

1. Department of Medicinal Chemistry, Tokyo University of Pharmacy and Life Sciences, 1432-1 Horinouchi, Hachioji, Tokyo 192-0392, Japan

2. Faculty of Pharmaceutical Sciences, Hokkaido University, Kita-12, Nishi-6, Kita-ku, Sapporo, Hokkaido 060-0812, Japan

3. Research Center, Mochida Pharmaceutical Co., Ltd., 722 Jimba-aza-Uenohara, Gotemba, Shizuoka 412-8524, Japan

4. Department of Dermatology, Hokkaido University Graduate School of Medicine, North 15 West 7, Kita-ku, Sapporo, Hokkaido 060-8638, Japan

5. Department of Dermatology, Institute of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki 305-8575, Japan

Funder

Japan Agency for Medical Research and Development

National Center of Neurology and Psychiatry

Japan Society for the Promotion of Science

Publisher

American Chemical Society (ACS)

Subject

Organic Chemistry,Drug Discovery,Biochemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/acsmedchemlett.3c00424

Reference34 articles.

1. A meta-analysis of nonsense mutations causing human genetic disease

2. Evidence-based path to newborn screening for duchenne muscular dystrophy

3. Gentamicin treatment of Duchenne and Becker muscular dystrophy due to nonsense mutations

4. Association of dystrophin and an integral membrane glycoprotein

5. Dystrophin-associated proteins in muscular dystrophy